Jiong Zhao to Breast Neoplasms
This is a "connection" page, showing publications Jiong Zhao has written about Breast Neoplasms.
Connection Strength
0.179
-
Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib. J Med Chem. 2020 07 09; 63(13):7186-7210.
Score: 0.071
-
Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer. J Med Chem. 2017 02 23; 60(4):1325-1342.
Score: 0.056
-
Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer. J Med Chem. 2016 Jan 14; 59(1):219-237.
Score: 0.052